Journal of Thermal Analysis and Calorimetry

, Volume 105, Issue 2, pp 645–650 | Cite as

Thermal degradation behavior of some ruthenium complexes with fluoroquinolone derivatives as potential antitumor agents

  • Valentina Uivarosi
  • Mihaela Badea
  • Rodica Olar
  • Dana Marinescu
  • Teodor Octavian Nicolescu
  • George Mihai Nitulescu
Article

Abstract

Three new complexes with ligands belong to the fluoroquinolone class having the general formula [RuL2Cl2]Cl nH2O ((1) L: norfloxacin (nf), n = 4; (2) L: ciprofloxacin (cp), n = 3; (3) L: enrofloxacin (enro), n = 5) were synthesized and characterized by chemical analysis UV–Vis and IR spectroscopy. In all complexes fluoroquinolone derivative acts as bidentate chelate ligand. The thermal behavior steps were investigated in synthetic air flow. The thermal transformations are complex processes according to TG and DTG curves including dehydration, quinolone derivative degradation, as well as RuCl3 conversion in RuO2.

Keywords

Fluoroquinolone Ruthenium complexes Thermal behavior 

Notes

Acknowledgements

This study was partially supported by the PNII Grant no. 61-48/2007 of the Romanian Ministry of Education and Research.

References

  1. 1.
    Levine C, Hiasa H, Mariabs KJ. Biochim Biophys Acta. 1998;1400:29–43.Google Scholar
  2. 2.
    Drlica K. Mechanism of fluoroquinolone action. Curr Opin Microbiol. 1999;2:504–8.CrossRefGoogle Scholar
  3. 3.
    Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61:377–92.Google Scholar
  4. 4.
    Buchbinder M, Webb JC, Anderson LV, McCabe WR. Laboratory studies and clinical pharmacology of nalidixic acid (WIN 18, 320). Antimicrob Agents Chemother. 1962;2:308–17.Google Scholar
  5. 5.
    Andriole V. The quinolones. New York: Academic Press; 1999.Google Scholar
  6. 6.
    Cheng D, Xu WR, Liu CX. Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials. World J Gastroenterol. 2007;13:2496–503.Google Scholar
  7. 7.
    Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002;65:455–64.Google Scholar
  8. 8.
    Souza MJ, Bittencourt CF, Morsch LM. LC determination of enrofloxacin. J Pharm Biomed Anal. 2002;28:1195–9.CrossRefGoogle Scholar
  9. 9.
    Fan JY, Sun D, Yu H, Kerwin SM, Hurley LH. Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. J Med Chem. 1995;38:408–24.CrossRefGoogle Scholar
  10. 10.
    Ameyama S, Shinmura Y, Takahata M. Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae. Antimicrob Agents Chemother. 2003;47:2327–9.CrossRefGoogle Scholar
  11. 11.
    Al-Mustafa J. Magnesium, calcium and barium perchlorate complexes of ciprofloxacin and norfloxacin. Acta Chim Slov. 2002;49:457–66.Google Scholar
  12. 12.
    Sadeek SA. Synthesis, thermogravimetric analysis, infrared, electronic and mass spectra of Mn(II), Co(II) and Fe(III) norfloxacin complexes. J Mol Struct. 2005;753:1–12.CrossRefGoogle Scholar
  13. 13.
    Jiménez-Garrido N, Perelló L, Ortiz R, Alzuet G, González-Álvarez M, Cantón E, Liu-González M, García-Granda S, Pérez-Priede M. Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin. J Inorg Biochem. 2005;99:677–89.CrossRefGoogle Scholar
  14. 14.
    Vieira LMM, de Almeida MV, Lourenço MCS, Bezerra FAFM, Fontes APS. Synthesis and antitubercular activity of palladium and platinum complexes with fluoroquinolones. Eur J Inorg Chem. 2009;44:4107–11.Google Scholar
  15. 15.
    Ruíz P, Ortiz R, Perelló LL, Alzuet G, González-Álvarez M, Liu-González M, Sanz-Ruíz F. Synthesis, structure, and nuclease properties of several binary and ternary complexes of copper(II) with norfloxacin and 1, 10 phenantroline. J Inorg Biochem. 2007;101:831–40.CrossRefGoogle Scholar
  16. 16.
    Refat MS, Mohamed GG, de Farias RF, Powell AK, Mohamed MS, El-Korashy SA, Hussien MA. Spectroscopic, thermal and kinetic studies of coordination compounds of Zn(II), Cd(II) and Hg(II) with norfloxacin. J Therm Anal Calorim. 2010;102:225–32. doi: 10.1007/s10973-009-0404-x.CrossRefGoogle Scholar
  17. 17.
    López-Gresa MP, Ortiz R, Perelló L, Latorre J, Liu-González M, García-Granda S, Pérez-Priede M, Cantón E. Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies. J Inorg Biochem. 2002;92:65–74.CrossRefGoogle Scholar
  18. 18.
    Obaleye JA, Akinremi CA, Balogun EA, Adebayo JO. Toxicological studies and antimicrobial properties of some iron(III) complexes of ciprofloxacin. Afr J Biotechnol. 2007;6:2826–32.Google Scholar
  19. 19.
    Clarke MJ, Zhu FC, Frasca DR. Non-platinum chemotherapeutic metallopharmaceuticals. Chem Rev. 1999;99:2511–33.CrossRefGoogle Scholar
  20. 20.
    Durig JR, Danneman J, Behnke WD, Mercer EE. The induction of filamentous growth in Escherichia coli by ruthenium and palladium complexes. Chem Biol Interact. 1976;13:287–94.CrossRefGoogle Scholar
  21. 21.
    Bergamo A, Gava B, Alessio E, Mestroni G, Serli B, Cocchietto M, Zorzet S, Sava G. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity. Int J Oncol. 2002;21:1331–8.Google Scholar
  22. 22.
    Lipponer KG, Vogel E, Keppler BK. Synthesis, characterization and solution chemistry of transindazoliumtetrachlorobis(indazole)ruthenate(III), a new anticancer ruthenium complex. IR, UV, NMR, HPLC investigations and antitumor activity. Crystal structures of trans-l-methylindazoliumtetrachlorobis-(1-methylindazole)ruthenate(III) and its hydrolysis product trans-monoaquatrichlorobis-(1-methylindazole)-ruthenate(III). Met Based Drugs. 1996;3:243–60.CrossRefGoogle Scholar
  23. 23.
    Hartinger CG, Zorbas-Seifried S, Jakupec M, Kynast B, Zorbas H, Keppler BK. From bench to bedside–preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). J Inorg Biochem. 2006;100:891–904.CrossRefGoogle Scholar
  24. 24.
    Scherzer J, Clapp LB. Ruthenium complexes with ethylenediaminetetraacetic acid. J Inorg Nucl Chem. 1968;30:1107–9.CrossRefGoogle Scholar
  25. 25.
    Matsubara T, Creutz C. Properties and reactivities of pentadentate ethylenediaminetetraacetate complexes of ruthenium(III) and -(II). Inorg Chem. 1979;18:1956–66.CrossRefGoogle Scholar
  26. 26.
    Vilaplana-Serrano R, Basallote MG, Ruiz-Valero C, Gutiérrez-Puebla E, González-Vílchez F. Synthesis and X-ray structural study of a novel ruthenium (III)–ethylenediaminetetraacetate complex. The first compound showing an unusual coordination site for a carboxylic (glycine) group. J Chem Soc Chem Commun. 1991;100–1.Google Scholar
  27. 27.
    González-Vílchez F, Vilaplana R, Blasco G, Messori L. Solution studies of the antitumor complex dichloro 1, 2-propylendiaminetetraacetate ruthenium (III) and of its interactions with proteins. J Inorg Biochem. 1998;71:45–51.CrossRefGoogle Scholar
  28. 28.
    Badea M, Olar R, Marinescu D, Uivarosi V, Nicolescu TO, Iacob D. Thermal study of some new quinolone ruthenium (III) complexes with potential cytostatic activity. J Therm Anal Calorim. 2010;99:829–34.CrossRefGoogle Scholar
  29. 29.
    Badea M, Olar R, Marinescu D, Uivarosi V, Iacob D. Thermal decomposition of some biologically active complexes of ruthenium (III) with quinolone derivatives. J Therm Anal Calorim. 2009;97:735–9.CrossRefGoogle Scholar
  30. 30.
    Deacon GB, Philips JR. Relationships between the carbon-oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord Chem Rev. 1980;33:227–50.CrossRefGoogle Scholar
  31. 31.
    Lever ABP. Inorganic electronic spectroscopy. Amsterdam, London, New York: Elsevier; 1986. p. 454.Google Scholar
  32. 32.
    Zhang JJ, Ge LG, Zhang XL, Dai YJ, Chen HL, Mo PL. Thermal decomposition kinetics of the Zn(II) complex with norfloxacin in static air atmosphere. J Therm Anal Calorim. 1999;58:269–78.CrossRefGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2010

Authors and Affiliations

  • Valentina Uivarosi
    • 1
  • Mihaela Badea
    • 2
  • Rodica Olar
    • 2
  • Dana Marinescu
    • 2
  • Teodor Octavian Nicolescu
    • 3
  • George Mihai Nitulescu
    • 4
  1. 1.Department of Inorganic ChemistryCarol Davila University of Medicine and PharmacyBucharestRomania
  2. 2.Faculty of Chemistry, Department of Inorganic ChemistryUniversity of BucharestBucharestRomania
  3. 3.Department of Organic ChemistryCarol Davila University of Medicine and PharmacyBucharestRomania
  4. 4.Department of Pharmaceutical ChemistryCarol Davila University of Medicine and PharmacyBucharestRomania

Personalised recommendations